Phosphorus-nitrogen compounds. 24. Phosphoramide mustard carrier derivatives
作者:Lindley A. Cates、Ven Shun Li、Douglas R. Powell、Dick Van der Helm
DOI:10.1021/jm00369a028
日期:1984.3
respectively. The propranolol derivative gave two racemic mixtures, which were tested to ascertain any differences in anticancer activity. The insertion of a P = O group between the carrier and oncolytic portions offsets the excess lipophilic contribution of the latter and possibly provides for latentiation of alkylating activity. Murine tumor testing of the phosphoramide mustard derivatives and two intermediates
己烯雌酚,补骨脂素和普萘洛尔被用作潜在的载体分子,分别在乳房,皮肤和肺组织中选择性浓缩氮芥子气部分。普萘洛尔衍生物产生两种外消旋混合物,经测试可确定其抗癌活性的任何差异。在载体和溶瘤部分之间插入P = O基团可抵消后者的过量亲脂作用,并可能提供烷基化活性的潜伏作用。对磷酰胺芥末衍生物和两种中间体的小鼠肿瘤测试表明,两种化合物对乳癌和淋巴细胞性白血病具有边缘活性。